Who owns Traws Pharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TRAW from SEC Form 13F filings across 34 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 34 institutions disclosed 6.2M shares of Traws Pharma, Inc. worth $5.1M — about 38.8% of shares outstanding; the largest disclosed holder is ORBIMED ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
34
13F holders
$5.1M
value, 2026 filers
38.8%
of shares outstanding (6.2M sh)
13
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TRAW's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 1.2M | $1.0M | 0.0% | 7.6% | +98.7% |
| 2 | Ally Bridge Group (NY) LLCNEW | 786,236 | $663,033 | 0.6% | 5% | new |
| 3 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 730,000 | $615,609 | 0.0% | 4.6% | 0.0% |
| 4 | ADAR1 Capital Management, LLC | 597,729 | $504,065 | 0.0% | 3.8% | +287.9% |
| 5 | Lynx1 Capital Management LP | 559,470 | $471,801 | 0.1% | 3.5% | +3610.5% |
| 6 | Ikarian Capital, LLC | 478,142 | $403,217 | 0.0% | 3% | -29.5% |
| 7 | SPHERA FUNDS MANAGEMENT LTD.NEW | 398,486 | $336,043 | 0.0% | 2.5% | new |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 330,049 | $278,231 | 0.0% | 2.1% | +498.0% |
| 9 | JANE STREET GROUP, LLC | 216,006 | $182,158 | 0.0% | 1.4% | +916.9% |
| 10 | Alyeska Investment Group, L.P.NEW | 164,376 | $138,618 | 0.0% | 1% | new |
| 11 | BOOTHBAY FUND MANAGEMENT, LLC | 133,936 | $112,948 | 0.0% | 0.8% | -31.2% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 111,365 | $93,915 | 0.0% | 0.7% | +44.4% |
| 13 | HRT FINANCIAL LPNEW | 91,220 | $76 | 0.0% | 0.6% | new |
| 14 | Kynam Capital Management, LPNEW | 84,400 | $71,175 | 0.0% | 0.5% | new |
| 15 | Dauntless Investment Group, LLC | 80,574 | $67,948 | 0.1% | 0.5% | -80.7% |
| 16 | VANGUARD FIDUCIARY TRUST CO | 54,511 | $45,953 | 0.0% | 0.3% | +71.4% |
| 17 | NORTHERN TRUST CORPNEW | 37,454 | $31,585 | 0.0% | 0.2% | new |
| 18 | STATE STREET CORP | 25,802 | $21,759 | 0.0% | 0.2% | 0.0% |
| 19 | XTX Topco LtdNEW | 18,092 | $15,257 | 0.0% | 0.1% | new |
| 20 | SG Americas Securities, LLCNEW | 14,524 | $12 | 0.0% | 0.1% | new |
| 21 | Virtu Financial LLCNEW | 12,579 | $11 | 0.0% | 0.1% | new |
| 22 | BlackRock, Inc. | 9,941 | $8,383 | 0.0% | 0.1% | -0.2% |
| 23 | Tower Research Capital LLC (TRC) | 5,142 | $4,336 | 0.0% | 0% | +29.7% |
| 24 | HUNTINGTON NATIONAL BANKNEW | 4,676 | $3,943 | 0.0% | 0% | new |
| 25 | UBS Group AG | 3,451 | $2,909 | 0.0% | 0% | -14.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.